A phase I, open-label, multicenter, single-dose escalation and multi-dose study of a monoclonal antibody targeting CEACAM1 in subjects with selected advanced or recurrent malignancies.

被引：0
|
作者：
Shapira, Roni
Weber, Jeffrey S.
Geva, Ravit
Sznol, Mario
Kluger, Harriet M.
Wong, Deborah J. L.
Liang, Bertrand C.
机构：
[1] Chaim Sheba Med Ctr, Tel Hashomer, Israel
[2] NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[3] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[4] Yale New Haven Med Ctr, Yale Sch Med, 20 York St, New Haven, CT 06504 USA
[5] Yale New Haven Med Ctr, Smilow Canc Ctr, 20 York St, New Haven, CT 06504 USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
[7] Kitov Pharma, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3094
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase 1, open-label, dose escalation study of the safety and tolerability of T3011 in advanced cutaneous or subcutaneous malignancies.
    Haydon, Andrew Mark
    Kichenadasse, Ganessan
    Kirkwood, John M.
    Kaufman, Howard E.
    Buchbinder, Elizabeth Iannotti
    Ganju, Vinod
    Barve, Minal A.
    Jiang, Haifang
    Xu, Huinan
    Zhou, Xusha
    Zhu, Huan J.
    Ni, Dongyao
    Niu, Jiaxin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
    Zonder, Jeffrey A.
    Mohrbacher, Ann F.
    Singhal, Seema
    van Rhee, Frits
    Bensinger, William I.
    Ding, Han
    Fry, John
    Afar, Daniel E. H.
    Singhal, Anil K.
    BLOOD, 2012, 120 (03) : 552 - 559
  • [3] Phase I dose-escalation, open-label study of HSP990 administered orally in adult patients with advanced solid malignancies.
    De Mattos-Arruda, Leticia
    Siu, Lillian L.
    Cortes, Javier
    Berge, Yann
    Razak, Albiruni R. A.
    Ahnert, Jordi Rodon
    Cottura, Ewa
    Bedard, Philippe
    Akimov, Mikhail
    Lu, Hong
    Pain, Scott
    Kaag, Audrey
    Delord, Jean-Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies
    Fountzilas, Christos
    Javle, Milind
    Tan, Wei
    Ma, Yingyu
    Fetterly, Gerald
    Iyer, Renuka
    Johnson, Candace
    CANCER, 2018, 124 (19) : 3890 - 3899
  • [5] DARATUMUMAB, A CD38 MONOCLONAL ANTIBODY STUDY IN ADVANCED MULTIPLE MYELOMA - AN OPEN-LABEL, DOSE ESCALATION FOLLOWED BY OPEN-LABEL EXTENSION IN A SINGLE-ARM PHASE I/II STUDY
    Lokhorst, H.
    Plesner, T.
    Gimsing, P.
    Nahi, H.
    Lisby, S.
    Richardson, P.
    HAEMATOLOGICA, 2013, 98 : 241 - 241
  • [6] A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies
    Lubner, Sam Joseph
    Mullvain, Jacqueline
    Perlman, Scott
    Pishvaian, Michael
    Mortimer, Joanne
    Oliver, Katherine
    Heideman, Jennifer
    Hall, Lance
    Weichert, Jamey
    Liu, Glenn
    CANCER INVESTIGATION, 2015, 33 (10) : 483 - 489
  • [7] Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
    Minami, Hironobu
    Ando, Yuichi
    Ma, Brigette Buig Yue
    Lee, Jih-Hsiang
    Momota, Hiroyuki
    Fujiwara, Yutaka
    Li, Leung
    Fukino, Koichi
    Ito, Koji
    Tajima, Takeshi
    Mori, Asuka
    Lin, Chia-Chi
    CANCER SCIENCE, 2016, 107 (10) : 1477 - 1483
  • [8] Phase I open-label, multiple ascending dose trial of MSB0010718C, an anti-PD-L1 monoclonal antibody, in advanced solid malignancies.
    Heery, Christopher Ryan
    Coyne, Geraldine Helen O'Sullivan
    Madan, Ravi Amrit
    Schlom, Jeffrey
    von Heydebreck, Anja
    Cuillerot, Jean-Marie
    Sabzevari, Helen
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes
    Sacks, SL
    Shafran, SD
    Diaz-Mitoma, F
    Trottier, S
    Sibbald, RG
    Hughes, A
    Safrin, S
    Rudy, J
    McGuire, B
    Jaffe, HS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2996 - 2999
  • [10] A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of Sgr-1505 As Monotherapy in Subjects with Mature B-Cell Malignancies
    Olszewski, Adam
    Kahn, David
    Yoo, Brian
    Tan, Joanne B. L.
    Gupta, Vipul K.
    Schuck, Edgar
    Nie, Zhe
    Krilov, Goran
    Wright, D. Hamish
    Weiss, Daniel
    Lachowicz, Jean
    Akinsanya, Karen
    Yin, Wu
    BLOOD, 2023, 142
12345